These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 6378591)

  • 21. Insulin and glucagon degradation by the kidney. I. Subcellular distribution under different assay condition.
    Duckworth WC
    Biochim Biophys Acta; 1976 Jul; 437(2):518-30. PubMed ID: 8105
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Electrophoretic analysis of membrane proteases in the luteinized rat ovary.
    Roche PC; Ryan RJ
    Endocrinology; 1986 Aug; 119(2):495-501. PubMed ID: 3525119
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prolactin influence on cytosol and nuclear androgen receptors in the ventral, dorsal, and lateral lobes of the rat prostate.
    Prins GS
    Endocrinology; 1987 Apr; 120(4):1457-64. PubMed ID: 3493896
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization and applications of monoclonal antibodies to the prolactin receptor.
    Okamura H; Zachwieja J; Raguet S; Kelly PA
    Endocrinology; 1989 May; 124(5):2499-508. PubMed ID: 2707162
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatic prolactin receptors in the rat: characterization using monoclonal antireceptor antibodies.
    Katoh M; Raguet S; Zachwieja J; Djiane J; Kelly PA
    Endocrinology; 1987 Feb; 120(2):739-49. PubMed ID: 3803302
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [125I]-insulin metabolism by the rat liver in vivo: evidence that a neutral thiol-protease mediates rapid intracellular insulin degradation.
    Williams FG; Johnson DE; Bauer GE
    Metabolism; 1990 Mar; 39(3):231-41. PubMed ID: 2407925
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proteolytic cleavage of human growth hormone (hGH) by rat tissues in vitro: influence on the kinetics of exogenously administered hGH.
    Wroblewski VJ; Masnyk M; Becker GW
    Endocrinology; 1991 Jul; 129(1):465-74. PubMed ID: 2055201
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prolactin binding in the rat ventral prostate.
    Hanlin ML; Yount AP
    Endocr Res Commun; 1975; 2(8):489-502. PubMed ID: 816636
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The 22K variant of rat prolactin: evidence for identity to prolactin-(1-173), storage in secretory granules, and regulated release.
    Anthony PK; Stoltz RA; Pucci ML; Powers CA
    Endocrinology; 1993 Feb; 132(2):806-14. PubMed ID: 8425495
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endocytosis and degradation of ovine prolactin by Nb2 lymphoma cells: characterization and effects of agents known to alter prolactin-induced mitogenesis.
    Augustine EC; Kensinger RS
    Endocrinology; 1990 Jul; 127(1):200-10. PubMed ID: 2113865
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antiidiotypic antibodies raised against anti-prolactin (PRL) antibodies recognize the PRL receptor.
    Amit T; Barkey RJ; Gavish M; Youdim MB
    Endocrinology; 1986 Feb; 118(2):835-43. PubMed ID: 3002768
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression and hormone regulation of prolactin receptors in rat dorsal and lateral prostate.
    Nevalainen MT; Valve EM; Ingleton PM; Härkönen PL
    Endocrinology; 1996 Jul; 137(7):3078-88. PubMed ID: 8770934
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of the prolactin receptor in human prostate.
    Leake A; Chisholm GD; Habib FK
    J Endocrinol; 1983 Nov; 99(2):321-8. PubMed ID: 6197504
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunoreactive prolactin in the rat hypothalamus: in vitro release and subcellular localization.
    DeVito WJ; Connors JM; Hedge GA
    Neuroendocrinology; 1987 Aug; 46(2):155-61. PubMed ID: 3627376
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prolactin proteolysis by glandular kallikrein: in vitro reaction requirements and cleavage sites, and detection of processed prolactin in vivo.
    Powers CA; Hatala MA
    Endocrinology; 1990 Oct; 127(4):1916-27. PubMed ID: 2401236
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A new mechanism for prolactin processing into 16K PRL by secreted cathepsin D.
    Piwnica D; Fernandez I; Binart N; Touraine P; Kelly PA; Goffin V
    Mol Endocrinol; 2006 Dec; 20(12):3263-78. PubMed ID: 16959874
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tripeptide aldehyde protease inhibitors may depress in vitro prolactin and growth hormone release.
    Nagy I; Makara GB; Horváth G; Rappay G; Kurcz M; Bajusz S
    Endocrinology; 1985 Apr; 116(4):1426-32. PubMed ID: 3971921
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proteolytic modification of growth hormone by a rat kidney lysosomal protease.
    Retegui LA; Scaramal LO; Paladini AC
    Acta Physiol Pharmacol Latinoam; 1987; 37(4):521-32. PubMed ID: 3078932
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of thyrotropin-releasing hormone on prolactin compartments in normal rat pituitary cells in primary culture.
    Morin A; Rosenbaum E; Tixier-Vidal A
    Endocrinology; 1984 Dec; 115(6):2278-84. PubMed ID: 6437795
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cathepsin D is the primary protease for the generation of adenohypophyseal vasoinhibins: cleavage occurs within the prolactin secretory granules.
    Cruz-Soto ME; Cosío G; Jeziorski MC; Vargas-Barroso V; Aguilar MB; Cárabez A; Berger P; Saftig P; Arnold E; Thebault S; Martínez de la Escalera G; Clapp C
    Endocrinology; 2009 Dec; 150(12):5446-54. PubMed ID: 19819948
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.